Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy.

Journal: Diabetes research and clinical practice
PMID:

Abstract

AIMS: Evaluate efficacy and hypoglycaemia according to concomitant oral antidiabetes drug (OAD) in people with type 2 diabetes initiating insulin glargine 100U/mL (Gla-100) or neutral protamine Hagedorn (NPH) insulin once daily.

Authors

  • David R Owens
    Institute of Life Sciences, Swansea University, Swansea, UK. Electronic address: OwensDR@cardiff.ac.uk.
  • Louise Traylor
    Sanofi US, Inc., Bridgewater, NJ, USA.
  • Peter Mullins
    Department of Statistics, University of Auckland, Auckland, New Zealand.
  • Wolfgang Landgraf
    Sanofi, Frankfurt, Germany.